Combination of HAI-FUDR and Systemic Gemcitabine and Cisplatin in Unresectable Cholangiocarcinoma: A Dose Finding Single Center Study

BACKGROUND: Unresectable cholangiocarcinoma has a poor prognosis and treatment options are limited. Combined systemic and intrahepatic chemotherapy may improve local control and enable downsizing. The aim of this study was to determine the maximum tolerated dose (MTD) of intravenous gemcitabine comb...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncology
Main Authors: Pietge, Heike, Sánchez-Velázquez, Patricia, Akhoundova, Dilara, Siebenhüner, Alexander, Winder, Thomas, Bachmann, Helga, Nguyen-Kim, Thi Dan Linh, Breitenstein, Stefan, Knuth, Alexander, Petrowsky, Henrik, Pestalozzi, Bernhard, Clavien, Pierre-Alain, Samaras, Panagiotis
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2021
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8117395/
https://ncbi.nlm.nih.gov/pubmed/33657549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000512967
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados